4//SEC Filing
Currie Mark G 4
Accession 0000950170-25-085440
CIK 0001446847other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:27 PM ET
Size
14.9 KB
Accession
0000950170-25-085440
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2025-06-10+45,000→ 613,419 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001478244
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:27 PM ET
- Size
- 14.9 KB